ReviewHarm reduction journal2023
Point-of-care community drug checking technologies: an insider look at the scientific principles and practical considerations.
Review in Harm reduction journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder.Journal of addiction medicineGuideline
- Integrating Medications for Addiction Treatment into Assertive Community Treatment Teams: A Pilot Feasibility Study.Community mental health journal · 2026Article
- Neural Network-Based Detection of Adulterants in Opioid Samples Using IR Absorption Spectroscopy.Drug testing and analysis · 2026Article
- Temporal and regional associations between fentanyl concentrations in the unregulated drug supply and drug-related mortality in British Columbia, Canada.The International journal on drug policy · 2026Article
- Development and validation of a fentanyl quantification model for drug checking services.Drug and alcohol dependence reports · 2026Article
- Fentanyl, Amphetamine-type Stimulants, Heroin, and xylazine in drug residues in two Northern border Mexican cities.Harm reduction journal · 2025Article
- Point-Of-Care Drug-Checking: Assessing the Rhode Island Drug Supply Using FTIR Spectroscopy to Detect Fentanyl, Xylazine and Other Substances.Drug and alcohol review · 2025Article
- From trash to results: shortcomings and benefits of paraphernalia-based drug checking in Finland.Harm reduction journal · 2025Article
- The emergence of nitazenes: a new chapter in the synthetic opioid crisis.Archives of toxicology · 2025Review
- Modern Methods for Detection of Fentanyl and Its Analogues: A Comprehensive Review of Technologies and Applications.Molecules (Basel, Switzerland) · 2025Review
- Community-based drug checking at syringe service programs in New York City observe an increasing prevalence of xylazine from 2021 through 2024.Harm reduction journal · 2025Article
- Detection of benzodiazepines in the unregulated drug supply using point of care and confirmatory drug checking technologies: A validation study.Drug and alcohol dependence · 2025Article
- Field-Portable Technology for Illicit Drug Discrimination via Deep Learning of Hybridized Reflectance/Fluorescence Spectroscopic Fingerprints.Analytical chemistry · 2025Article
- Characteristics of take-home fentanyl test strip use and support for drug checking services among people who use heroin in Australia: learnings for an increasingly complex drug market.Harm reduction journal · 2025Article
- Is fentanyl in everything? Examining the unexpected occurrence of illicit opioids in British Columbia's drug supply.Harm reduction journal · 2025Article
- Field-Portable Device for Detection of Controlled and Psychoactive Substances from e-Cigarettes.ACS omega · 2025Article
- Ecstasy, molly, MDMA: What health practitioners need to know about this common recreational drug.Disease-a-month : DM · 2025Review
- A systematic review of sensors to combat crime and routes to further sensor development.Frontiers in chemistry · 2025Review
- An implementation science study of a campus-based drug checking service at a Canadian university.PloS one · 2025Article
- "All You Can Do is What You Know to Do": Naloxone Knowledge and Uncertainty Among People Who Use Drugs in Maryland amid a Volatile Drug Market.Substance use & misuse · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Drug checking is increasingly being explored outside of festivals and events to be an ongoing service within communities, frequently integrated within responses to illicit drug overdose. The choice of instrumentation is a common question, and the demands on these chemical analytical instruments can be challenging as illicit substances may be more complex and include highly potent ingredients at trace levels. The answer remains nuanced as the instruments themselves are not directly comparable nor are the local demands on the service, meaning implementation factors heavily influence the assessment and effectiveness of instruments. In this perspective, we provide a technical but accessible introduction to the background of a few common drug checking methods aimed at current and potential drug checking service providers. We discuss the following tools that have been used as part of the Vancouver Island Drug Checking Project in Victoria, Canada: immunoassay test strips, attenuated total reflection IR-absorption spectroscopy, Raman spectroscopy from powder samples, surface-enhanced Raman scattering in a solution of colloidal gold nanoparticles, and gas chromatography-mass spectrometry. Using four different drug mixtures received and tested at the service, we illustrate the strengths, limitations, and capabilities of such instruments, and expose the scientific theory to give further insight into their analytical results. Each case study provides a walk-through-style analysis for a practical comparison between data from several different instruments acquired on the same sample. Ideally, a single instrument would be able to achieve all of the objectives of drug checking. However, there is no clear instrument that ticks every box; low cost, portable, rapid, easy-to-use and provides highly sensitive identification and accurate quantification. Multi-instrument approaches to drug checking may be required to effectively respond to increasingly complex and highly potent substances demanding trace level detection and the potential for quantification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.